fig4
Figure 4. EV-NID1-treated DCs promote the proliferation and Treg differentiation of CD4+ T cells. (A) Schematic diagram of the co-culture of CD4+ T cells and BMDCs. CD4+ T cells isolated by magnetic bead sorting were co-cultured with BMDCs subjected to different treatments (ratio, 1:1), and cells were harvested after 72 h for flow cytometry analysis; (B) Analysis of CD4+ T cell proliferation by flow cytometry after co-culture with NID1 NC EV (10 μg/mL), NID1 KD EV (10 μg/mL), or LPS (50 ng/mL); (C) Analysis of Treg proportion in CD4+ T cells by flow cytometry after co-culture with NID1 NC EV (10 μg/mL), NID1 KD EV (10 μg/mL), or LPS (50 ng/mL). Data are presented as the mean ± SD, with statistical significance determined by one-way ANOVA (Tukey’s test). Biological replicates are represented as individual data points. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. NID1: Nidogen 1; NC: negative control; KD: knockdown; EV: extracellular vesicle; DC: dendritic cell; BMDC: bone marrow-derived dendritic cell; CD4: cluster of differentiation 4; Treg: regulatory T cell; FOXP3: forkhead box protein P3; IL-2: interleukin-2; CFSE: carboxyfluorescein succinimidyl ester; CTV: CellTrace Violet; LPS: lipopolysaccharide; SD: standard deviation; ANOVA: analysis of variance; ns: not significant.





